Moderate Dems still seek changes to the party’s drug pricing package
Rep. Kurt Schrader (D-Ore.) is still pushing for changes to the proposal ahead of a key vote on the bill expected as soon as this week.
Rep. Kurt Schrader (D-Ore.) is still pushing for changes to the proposal ahead of a key vote on the bill expected as soon as this week.
The Biden administration will invest billions to expand Covid-19 vaccine manufacturing capacity. The effort was greeted with mixed reactions.
Wall Street is quickly discounting the possibility Biogen’s Alzheimer’s drug Aduhelm will generate revenues from the vast European market.
A panel of European drug reviewers notified Biogen that its Alzheimer’s treatment Aduhelm is unlikely to win approval there.
STAT spoke with Penny Heaton, a new leader of J&J’s vaccine division, about the company’s vaccine plans to combat Covid-19, RSV, and more.
A telehealth project to connect urban providers to rural patients with PTSD and bipolar disorder saw “huge gains.” Can the approach scale?
The US government will buy more doses of an antibody drug for early treatment of Covid-19 developed by GlaxoSmithKline and Vir Biotechnology.
Growing up poor, Sudhakar Nuti wanted to do right by his poor and immigrant patients. Burnout made that a challenge.
How some fish can live for more than 200 years, the questions swirling around new Alzheimer’s drugs and how one of the world’s last COVID-elimination strategies is panning out in China.
Bjerknes, J. Atmospheric teleconnections from the equatorial Pacific. Monthly Weather Review 97, 163-172 (1969). Cane, M. A. The evolution of El Niño, past and future. Earth and Planetary Science…